Invitation for Article Submission - Chemotherapy: Open Access


[ISSN: 2167-7700 | Index Copernicus Value: 62.73]

Greetings from Chemotherapy: Open Access!

Chemotherapy: Open Access is a prestigious Journal publishing Cancer and Chemotherapy research Articles. This unique Journal aims to publish complete and reliable source of information on the discoveries and current developments in the field of Cancer and Chemotherapy.

Journal deals with various types of therapeutic techniques such as Cytotoxic, Electro, and the antimicrobial chemotherapies used to treat several dreadful diseases, particularly Cancer. It also accepts articles on immune suppressant and its application along with different aspects of chemotherapy research and chemotherapy reviews. This scientific journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal.

Chemotherapy (CMT) is one of the best Open Access journals publishes the relevant and reliable information on the discoveries and current developments in the form of original articles, review articles, case reports, short communications, etc. and all other areas of the field and making them freely available online without any restrictions or any other subscriptions to researchers worldwide.

Journal invites eminent authors globally to publish their Scientific research Articles, Case reports, Mini reviews, Brief reports and short communications for upcoming issue (Volume 8, Issue 1).

To submit your valuable Article, please go through our online portal or send as an attachment to this E-mail:

We are going to release the upcoming issue of our Journal by the end of December and we would appreciate your submission on (or) before 23rd December 2019.

Note: As part of year end publishing, Journal providing maximum discount on Articles submitted for upcoming issue (Volume 8, Issue 1) in 2019.

If the date is not feasible kindly, let us know your date of submission.

We are Happy to assist you on further Queries.

Best wishes for your on-going research.


With Regards,

John George

Editorial Manger | Chemotherapy: Open Access